Literature DB >> 18230654

Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin.

Christian Benedict1, Werner Kern, Bernd Schultes, Jan Born, Manfred Hallschmid.   

Abstract

CONTEXT: Brain insulin is critically involved in the regulation of body weight and memory processing. Long-term administration of intranasal insulin reduces body weight in men, but not in women, while improving hippocampus-dependent memory processing in both genders.
OBJECTIVES: Our objectives were to assess the effects of a single dose of intranasal insulin on food intake and memory function in men and women, and to determine any gender differences.
METHODS: A total of 32 healthy, normal-weight subjects (14 men, 18 women) were intranasally administered 160 IU regular human insulin or vehicle before performing a hippocampus-dependent two-dimensional-object location task, a working memory task (digit span), and a hippocampus-independent mirror tracing task. Subsequently, food intake from an ad libitum breakfast buffet was measured.
RESULTS: Insulin treatment decreased food intake in men but not in women (difference to placebo condition, men: -192.57 +/- 78.48 kcal, P < 0.03; women: 18.54 +/- 42.89 kcal, P > 0.67). In contrast, hippocampus-dependent memory and working memory were improved in women (P < 0.03, P < 0.05, respectively), whereas men did not benefit from acute insulin treatment (P > 0.17, P > 0.20). Performance on the hippocampus-independent mirror tracing task was not affected by insulin in women or men.
CONCLUSIONS: In accordance with animal data, results indicate that men are more sensitive than women to the acute anorexigenic effect of central nervous insulin signaling, whereas insulin's beneficial effect on hippocampus-dependent memory functions is more pronounced in women. Our findings provide support for the notion of a fundamental gender difference in central nervous insulin signaling that pertains to the regulation of energy homeostasis and memory functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230654     DOI: 10.1210/jc.2007-2606

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  108 in total

1.  Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.

Authors:  Neil J Johnson; Leah R Hanson; William H Frey
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

2.  Insulin resistance is associated with poorer verbal fluency performance in women.

Authors:  Laura L Ekblad; Juha O Rinne; Pauli J Puukka; Hanna K Laine; Satu E Ahtiluoto; Raimo O Sulkava; Matti H Viitanen; Antti M Jula
Journal:  Diabetologia       Date:  2015-08-15       Impact factor: 10.122

Review 3.  Evidence for central regulation of glucose metabolism.

Authors:  Michelle Carey; Sylvia Kehlenbrink; Meredith Hawkins
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

Review 4.  Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.

Authors:  Vasileios-Arsenios Lioutas; Freddy Alfaro-Martinez; Francisco Bedoya; Chen-Chih Chung; Daniela A Pimentel; Vera Novak
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

Review 5.  Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.

Authors:  Suzanne M de la Monte
Journal:  Expert Opin Drug Deliv       Date:  2013-11-12       Impact factor: 6.648

Review 6.  Deregulation of brain insulin signaling in Alzheimer's disease.

Authors:  Yanxing Chen; Yanqiu Deng; Baorong Zhang; Cheng-Xin Gong
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

Review 7.  Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

Authors:  Fernanda G De Felice
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

Review 8.  Inconsistencies in the assessment of food intake.

Authors:  Stephen C Woods; Wolfgang Langhans
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

Review 9.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

10.  Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects.

Authors:  Manfred Hallschmid; Kamila Jauch-Chara; Oliver Korn; Matthias Mölle; Björn Rasch; Jan Born; Bernd Schultes; Werner Kern
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.